FTXH
FTXH
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to...
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 EXEL | Exelixis, Inc. | 0.00% | 8.59K | $461.42K |
 MEDP | Medpace Holdings, Inc. | 0.00% | 576 | $450.32K |
 MIRM | Mirum Pharmaceuticals, Inc. | 0.00% | 1.59K | $161.22K |
 BMRN | BioMarin Pharmaceutical Inc. | 0.00% | 5.04K | $345.21K |
 BMY | Bristol-Myers Squibb Company | 0.00% | 36.61K | $2.13M |
 SUPN | Supernus Pharmaceuticals, Inc. | 0.00% | 2.60K | $142.66K |
 SYRE | Spyre Therapeutics, Inc. | 0.00% | - | $257.94K |
 TARS | Tarsus Pharmaceuticals, Inc. | 0.00% | - | $135.29K |
 MRK | Merck & Co., Inc. | 0.00% | 20.54K | $2.12M |
 MRNA | Moderna, Inc. | 0.00% | - | $152.35K |
 NBIX | Neurocrine Biosciences, Inc. | 0.00% | 1.34K | $350.45K |
 CAH | Cardinal Health, Inc. | 0.00% | 5.80K | $1.03M |
 GH | Guardant Health, Inc. | 0.00% | 1.74K | $146.20K |
 GILD | Gilead Sciences, Inc. | 0.00% | 7.63K | $1.02M |
 TGTX | TG Therapeutics, Inc. | 0.00% | 4.00K | $178.38K |
 TVTX | Travere Therapeutics, Inc. | 0.00% | - | $207.93K |
 TWST | Twist Bioscience Corporation | 0.00% | - | $193.66K |
 TXG | 10x Genomics, Inc. | 0.00% | - | $171.89K |
 ABBV | AbbVie Inc. | 0.00% | 8.21K | $1.98M |
 BIIB | Biogen Inc. | 0.00% | 6.41K | $1.02M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
United KingdomSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland United KingdomHoldings (Top 20)
EXEL
Exelixis, Inc.
MEDP
Medpace Holdings, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
BMRN
BioMarin Pharmaceutical Inc.
BMY
Bristol-Myers Squibb Company
SUPN
Supernus Pharmaceuticals, Inc.
SYRE
Spyre Therapeutics, Inc.
TARS
Tarsus Pharmaceuticals, Inc.
MRK
Merck & Co., Inc.
MRNA
Moderna, Inc.
NBIX
Neurocrine Biosciences, Inc.
CAH
Cardinal Health, Inc.
GH
Guardant Health, Inc.
GILD
Gilead Sciences, Inc.
TGTX
TG Therapeutics, Inc.
TVTX
Travere Therapeutics, Inc.
TWST
Twist Bioscience Corporation
TXG
10x Genomics, Inc.
ABBV
AbbVie Inc.
BIIB
Biogen Inc.